Nanosonics Limited NAN.AX · Stock Open Nanosonics Limited in new tab
Analyst price targets
Recent rating changes, newest first
Nanosonics Limited Analysis (NAN.AX)
Is Nanosonics Limited a good investment? Nanosonics Limited (NAN.AX) is currently trading at 2.83 AUD. Market analysts have a consensus price target of 3.88 AUD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 47.67. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Nanosonics Limited is expected to release its next earnings report on Feb. 23, 2027. The market consensus estimate for Forward EPS is 0.05.
Investor FAQ
Does Nanosonics Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Nanosonics Limited?
Nanosonics Limited is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Feb. 23, 2027. The company currently has a trailing EPS of 0.06.
Company Profile
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Community Discussion